Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
For cell therapies, raw material quality hinges on the human touch
Pharmaphorum
Mon, 05/12/25 - 11:26 am
cell therapy
drug manufacturing
raw materials
quality control
Trump says he will sign order aimed at cutting drug prices to match other countries
USA Today
Sun, 05/11/25 - 10:10 pm
Donald Trump
most favored nation
drug pricing
Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial
Investing.com
Sun, 05/11/25 - 10:06 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
Zevaskyn Gets FDA Nod as First Cell Therapy for Rare, Debilitating Skin Disease
Xtalks
Sun, 05/11/25 - 10:02 pm
Abeona Therapeutics
zamikeracel
pz-cel
FDA
Zevaskyn
rare disease
The FDA approves first U.S. at-home tool as a Pap-smear alternative
NPR
Sun, 05/11/25 - 09:59 pm
FDA
cervical cancer
Teal Health
Medtech
pap smears
May 9 2025 - FDA chief Martin Makary sets June deadline for genAI rollout
Fri, 05/9/25 - 09:44 am
FDA chief Martin Makary sets June deadline for genAI rollout
Clinical Trials Arena
Fri, 05/9/25 - 09:41 am
FDA
Marty Makary
artificial intelligence
genAI
FDA layoffs could slow safety communications, experts warn
BioPharma Dive
Fri, 05/9/25 - 09:39 am
FDA
regulatory
drug safety
layoffs
recalls
FDA misses another approval decision target date, this time for GSK's Nucala in COPD
Fierce Pharma
Fri, 05/9/25 - 09:36 am
FDA
HHS
GSK
COPD
Nucala
regulatory
drug approvals
4 more biotechs cut staff amid market tumult
BioPharma Dive
Fri, 05/9/25 - 09:35 am
Vor Bio
Korro Bio
Insitro
Rallybio
biotech
layoffs
Qilu Pharmaceutical pays $38M upfront for greater China rights to Minghui's ADC
Fierce Biotech
Fri, 05/9/25 - 09:32 am
Qilu Pharmaceutical
China
Minguhui Pharmaceutical
Moderna’s flu-COVID vaccine beats standard shots
Beckers Hospital Review
Fri, 05/9/25 - 09:30 am
Moderna Therapeutics
MRNA
vaccines
flu-COVID combo vaccines
COVID-19
clinical trials
Leo tames eczema in phase 2b, reporting primary endpoint hit for ex-argenx asset
Fierce Biotech
Fri, 05/9/25 - 09:26 am
LEO Pharma
eczema
temtokibart
clinical trials
Senior Pharmaceutical Sales Specialist, Specialty Care CVRM - Roanoke, VA - AstraZeneca - Roanoke, Virginia, United States
Fri, 05/9/25 - 09:03 am
Johnson & Johnson (JNJ) reports Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
Marketscreener
Fri, 05/9/25 - 08:59 am
JNJ
clinical trials
icotrokinra
psoriasis
US, UK reach deal on tariffs, market access
Medtech Dive
Fri, 05/9/25 - 08:37 am
tariffs
Donald Trump
UK
AZ plots wider Imfinzi use in bladder cancer after trial win
Pharmaphorum
Fri, 05/9/25 - 08:30 am
AstraZeneca
Imfinzi
bladder cancer
clinical trials
Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures
Fierce Biotech
Fri, 05/9/25 - 08:28 am
Sanofi
IGM Biosciences
layoffs
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer
MedCity News
Thu, 05/8/25 - 10:54 pm
Verastem Oncology
ovarian cancer
KRAS mutation
FDA
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »